nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—TACR1—nerve—hypothyroidism	0.0347	0.155	CbGeAlD
Aprepitant—TACR3—cardiovascular system—hypothyroidism	0.0314	0.14	CbGeAlD
Aprepitant—CYP2C19—urine—hypothyroidism	0.0192	0.0856	CbGeAlD
Aprepitant—TACR3—cerebellum—hypothyroidism	0.019	0.0846	CbGeAlD
Aprepitant—Epigastric discomfort—Liotrix—hypothyroidism	0.0163	0.0252	CcSEcCtD
Aprepitant—CYP1A2—urine—hypothyroidism	0.0157	0.07	CbGeAlD
Aprepitant—CYP2C9—urine—hypothyroidism	0.0149	0.0664	CbGeAlD
Aprepitant—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0131	0.0202	CcSEcCtD
Aprepitant—Myocardial infarction—Liothyronine—hypothyroidism	0.013	0.0201	CcSEcCtD
Aprepitant—CYP3A4—urine—hypothyroidism	0.0114	0.0506	CbGeAlD
Aprepitant—Wheezing—Levothyroxine—hypothyroidism	0.0113	0.0175	CcSEcCtD
Aprepitant—Wheezing—Dextrothyroxine—hypothyroidism	0.0113	0.0175	CcSEcCtD
Aprepitant—TACR1—adrenal gland—hypothyroidism	0.00963	0.0429	CbGeAlD
Aprepitant—TACR1—blood—hypothyroidism	0.00962	0.0429	CbGeAlD
Aprepitant—Disorientation—Dextrothyroxine—hypothyroidism	0.00944	0.0146	CcSEcCtD
Aprepitant—Disorientation—Levothyroxine—hypothyroidism	0.00944	0.0146	CcSEcCtD
Aprepitant—TACR3—Peptide GPCRs—TSHR—hypothyroidism	0.00938	0.0726	CbGpPWpGaD
Aprepitant—Hypertension—Liothyronine—hypothyroidism	0.00894	0.0138	CcSEcCtD
Aprepitant—Wheezing—Liotrix—hypothyroidism	0.00831	0.0129	CcSEcCtD
Aprepitant—Tachycardia—Liothyronine—hypothyroidism	0.00825	0.0128	CcSEcCtD
Aprepitant—Blood urea increased—Liotrix—hypothyroidism	0.00808	0.0125	CcSEcCtD
Aprepitant—TACR1—testis—hypothyroidism	0.00796	0.0355	CbGeAlD
Aprepitant—Hypotension—Liothyronine—hypothyroidism	0.0079	0.0122	CcSEcCtD
Aprepitant—Dehydration—Dextrothyroxine—hypothyroidism	0.00786	0.0122	CcSEcCtD
Aprepitant—Dehydration—Levothyroxine—hypothyroidism	0.00786	0.0122	CcSEcCtD
Aprepitant—Muscular weakness—Levothyroxine—hypothyroidism	0.00745	0.0115	CcSEcCtD
Aprepitant—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00745	0.0115	CcSEcCtD
Aprepitant—Dysphagia—Levothyroxine—hypothyroidism	0.0073	0.0113	CcSEcCtD
Aprepitant—Dysphagia—Dextrothyroxine—hypothyroidism	0.0073	0.0113	CcSEcCtD
Aprepitant—Sweating increased—Levothyroxine—hypothyroidism	0.00711	0.011	CcSEcCtD
Aprepitant—Sweating increased—Dextrothyroxine—hypothyroidism	0.00711	0.011	CcSEcCtD
Aprepitant—Disorientation—Liotrix—hypothyroidism	0.00695	0.0107	CcSEcCtD
Aprepitant—Body temperature increased—Liothyronine—hypothyroidism	0.00668	0.0103	CcSEcCtD
Aprepitant—Weight decreased—Dextrothyroxine—hypothyroidism	0.00661	0.0102	CcSEcCtD
Aprepitant—Weight decreased—Levothyroxine—hypothyroidism	0.00661	0.0102	CcSEcCtD
Aprepitant—Renal impairment—Liotrix—hypothyroidism	0.00653	0.0101	CcSEcCtD
Aprepitant—CYP3A7—liver—hypothyroidism	0.00643	0.0287	CbGeAlD
Aprepitant—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00642	0.00993	CcSEcCtD
Aprepitant—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00642	0.00993	CcSEcCtD
Aprepitant—Myocardial infarction—Levothyroxine—hypothyroidism	0.00638	0.00987	CcSEcCtD
Aprepitant—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00638	0.00987	CcSEcCtD
Aprepitant—Blood creatinine increased—Liotrix—hypothyroidism	0.00582	0.00901	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0058	0.0449	CbGpPWpGaD
Aprepitant—Dehydration—Liotrix—hypothyroidism	0.00578	0.00894	CcSEcCtD
Aprepitant—Hypokalaemia—Liotrix—hypothyroidism	0.00566	0.00875	CcSEcCtD
Aprepitant—Muscular weakness—Liotrix—hypothyroidism	0.00548	0.00848	CcSEcCtD
Aprepitant—CYP3A7-CYP3A51P—liver—hypothyroidism	0.00547	0.0244	CbGeAlD
Aprepitant—Flushing—Dextrothyroxine—hypothyroidism	0.00542	0.00839	CcSEcCtD
Aprepitant—Flushing—Levothyroxine—hypothyroidism	0.00542	0.00839	CcSEcCtD
Aprepitant—Abdominal distension—Liotrix—hypothyroidism	0.00541	0.00837	CcSEcCtD
Aprepitant—Dysphagia—Liotrix—hypothyroidism	0.00537	0.00831	CcSEcCtD
Aprepitant—Sweating increased—Liotrix—hypothyroidism	0.00523	0.0081	CcSEcCtD
Aprepitant—Alopecia—Levothyroxine—hypothyroidism	0.00516	0.00799	CcSEcCtD
Aprepitant—Alopecia—Dextrothyroxine—hypothyroidism	0.00516	0.00799	CcSEcCtD
Aprepitant—TACR3—G alpha (q) signalling events—TRH—hypothyroidism	0.00502	0.0388	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00495	0.0383	CbGpPWpGaD
Aprepitant—Weight decreased—Liotrix—hypothyroidism	0.00486	0.00752	CcSEcCtD
Aprepitant—Tremor—Dextrothyroxine—hypothyroidism	0.00477	0.00738	CcSEcCtD
Aprepitant—Tremor—Levothyroxine—hypothyroidism	0.00477	0.00738	CcSEcCtD
Aprepitant—Acute coronary syndrome—Liotrix—hypothyroidism	0.00472	0.0073	CcSEcCtD
Aprepitant—Renal failure—Liotrix—hypothyroidism	0.00471	0.00728	CcSEcCtD
Aprepitant—Myocardial infarction—Liotrix—hypothyroidism	0.00469	0.00726	CcSEcCtD
Aprepitant—Angioedema—Dextrothyroxine—hypothyroidism	0.00465	0.00719	CcSEcCtD
Aprepitant—Angioedema—Levothyroxine—hypothyroidism	0.00465	0.00719	CcSEcCtD
Aprepitant—TACR1—Peptide GPCRs—TSHR—hypothyroidism	0.00458	0.0355	CbGpPWpGaD
Aprepitant—Palpitations—Levothyroxine—hypothyroidism	0.0045	0.00696	CcSEcCtD
Aprepitant—Palpitations—Dextrothyroxine—hypothyroidism	0.0045	0.00696	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00449	0.0347	CbGpPWpGaD
Aprepitant—Convulsion—Dextrothyroxine—hypothyroidism	0.00441	0.00682	CcSEcCtD
Aprepitant—Convulsion—Levothyroxine—hypothyroidism	0.00441	0.00682	CcSEcCtD
Aprepitant—Arthralgia—Dextrothyroxine—hypothyroidism	0.00433	0.0067	CcSEcCtD
Aprepitant—Arthralgia—Levothyroxine—hypothyroidism	0.00433	0.0067	CcSEcCtD
Aprepitant—Anxiety—Dextrothyroxine—hypothyroidism	0.00432	0.00668	CcSEcCtD
Aprepitant—Anxiety—Levothyroxine—hypothyroidism	0.00432	0.00668	CcSEcCtD
Aprepitant—Hypoaesthesia—Liotrix—hypothyroidism	0.00428	0.00662	CcSEcCtD
Aprepitant—Confusional state—Dextrothyroxine—hypothyroidism	0.00419	0.00648	CcSEcCtD
Aprepitant—Confusional state—Levothyroxine—hypothyroidism	0.00419	0.00648	CcSEcCtD
Aprepitant—Shock—Dextrothyroxine—hypothyroidism	0.00408	0.00632	CcSEcCtD
Aprepitant—Shock—Levothyroxine—hypothyroidism	0.00408	0.00632	CcSEcCtD
Aprepitant—Tachycardia—Levothyroxine—hypothyroidism	0.00405	0.00627	CcSEcCtD
Aprepitant—Tachycardia—Dextrothyroxine—hypothyroidism	0.00405	0.00627	CcSEcCtD
Aprepitant—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00401	0.00621	CcSEcCtD
Aprepitant—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00401	0.00621	CcSEcCtD
Aprepitant—Flushing—Liotrix—hypothyroidism	0.00399	0.00617	CcSEcCtD
Aprepitant—CYP2C9—heart—hypothyroidism	0.00382	0.017	CbGeAlD
Aprepitant—Alopecia—Liotrix—hypothyroidism	0.0038	0.00588	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00378	0.00585	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00378	0.00585	CcSEcCtD
Aprepitant—Insomnia—Dextrothyroxine—hypothyroidism	0.00376	0.00581	CcSEcCtD
Aprepitant—Insomnia—Levothyroxine—hypothyroidism	0.00376	0.00581	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00374	0.0289	CbGpPWpGaD
Aprepitant—Dyspnoea—Dextrothyroxine—hypothyroidism	0.0037	0.00573	CcSEcCtD
Aprepitant—Dyspnoea—Levothyroxine—hypothyroidism	0.0037	0.00573	CcSEcCtD
Aprepitant—Flatulence—Liotrix—hypothyroidism	0.00369	0.00571	CcSEcCtD
Aprepitant—CYP2C19—blood—hypothyroidism	0.00368	0.0164	CbGeAlD
Aprepitant—Dysgeusia—Liotrix—hypothyroidism	0.00366	0.00567	CcSEcCtD
Aprepitant—CYP2C9—cardiovascular system—hypothyroidism	0.0036	0.0161	CbGeAlD
Aprepitant—Fatigue—Levothyroxine—hypothyroidism	0.00358	0.00554	CcSEcCtD
Aprepitant—Fatigue—Dextrothyroxine—hypothyroidism	0.00358	0.00554	CcSEcCtD
Aprepitant—Tremor—Liotrix—hypothyroidism	0.00351	0.00543	CcSEcCtD
Aprepitant—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00342	0.00529	CcSEcCtD
Aprepitant—Feeling abnormal—Levothyroxine—hypothyroidism	0.00342	0.00529	CcSEcCtD
Aprepitant—Angioedema—Liotrix—hypothyroidism	0.00342	0.00529	CcSEcCtD
Aprepitant—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.0034	0.00525	CcSEcCtD
Aprepitant—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.0034	0.00525	CcSEcCtD
Aprepitant—Syncope—Liotrix—hypothyroidism	0.00336	0.00519	CcSEcCtD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00332	0.0257	CbGpPWpGaD
Aprepitant—Palpitations—Liotrix—hypothyroidism	0.00331	0.00512	CcSEcCtD
Aprepitant—Urticaria—Dextrothyroxine—hypothyroidism	0.0033	0.0051	CcSEcCtD
Aprepitant—Urticaria—Levothyroxine—hypothyroidism	0.0033	0.0051	CcSEcCtD
Aprepitant—Loss of consciousness—Liotrix—hypothyroidism	0.00329	0.00509	CcSEcCtD
Aprepitant—Abdominal pain—Levothyroxine—hypothyroidism	0.00328	0.00508	CcSEcCtD
Aprepitant—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00328	0.00508	CcSEcCtD
Aprepitant—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00328	0.00508	CcSEcCtD
Aprepitant—Body temperature increased—Levothyroxine—hypothyroidism	0.00328	0.00508	CcSEcCtD
Aprepitant—Convulsion—Liotrix—hypothyroidism	0.00324	0.00502	CcSEcCtD
Aprepitant—Hypertension—Liotrix—hypothyroidism	0.00323	0.005	CcSEcCtD
Aprepitant—Chest pain—Liotrix—hypothyroidism	0.00319	0.00493	CcSEcCtD
Aprepitant—Arthralgia—Liotrix—hypothyroidism	0.00319	0.00493	CcSEcCtD
Aprepitant—Anxiety—Liotrix—hypothyroidism	0.00317	0.00491	CcSEcCtD
Aprepitant—Confusional state—Liotrix—hypothyroidism	0.00308	0.00477	CcSEcCtD
Aprepitant—Anaphylactic shock—Liotrix—hypothyroidism	0.00305	0.00473	CcSEcCtD
Aprepitant—Oedema—Liotrix—hypothyroidism	0.00305	0.00473	CcSEcCtD
Aprepitant—Infection—Liotrix—hypothyroidism	0.00303	0.0047	CcSEcCtD
Aprepitant—Shock—Liotrix—hypothyroidism	0.003	0.00465	CcSEcCtD
Aprepitant—CYP1A2—blood—hypothyroidism	0.003	0.0134	CbGeAlD
Aprepitant—Tachycardia—Liotrix—hypothyroidism	0.00298	0.00461	CcSEcCtD
Aprepitant—Asthenia—Dextrothyroxine—hypothyroidism	0.00298	0.00461	CcSEcCtD
Aprepitant—Asthenia—Levothyroxine—hypothyroidism	0.00298	0.00461	CcSEcCtD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00296	0.0229	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00296	0.0229	CbGpPWpGaD
Aprepitant—Hyperhidrosis—Liotrix—hypothyroidism	0.00295	0.00457	CcSEcCtD
Aprepitant—Pruritus—Dextrothyroxine—hypothyroidism	0.00294	0.00455	CcSEcCtD
Aprepitant—Pruritus—Levothyroxine—hypothyroidism	0.00294	0.00455	CcSEcCtD
Aprepitant—Anorexia—Liotrix—hypothyroidism	0.00291	0.0045	CcSEcCtD
Aprepitant—CYP1A2—thyroid gland—hypothyroidism	0.0029	0.0129	CbGeAlD
Aprepitant—CYP3A5—blood—hypothyroidism	0.0029	0.0129	CbGeAlD
Aprepitant—CYP2C19—liver—hypothyroidism	0.00287	0.0128	CbGeAlD
Aprepitant—Hypotension—Liotrix—hypothyroidism	0.00285	0.00442	CcSEcCtD
Aprepitant—CYP2C9—blood—hypothyroidism	0.00285	0.0127	CbGeAlD
Aprepitant—Diarrhoea—Levothyroxine—hypothyroidism	0.00284	0.0044	CcSEcCtD
Aprepitant—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00284	0.0044	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00278	0.00431	CcSEcCtD
Aprepitant—Insomnia—Liotrix—hypothyroidism	0.00276	0.00427	CcSEcCtD
Aprepitant—Paraesthesia—Liotrix—hypothyroidism	0.00274	0.00424	CcSEcCtD
Aprepitant—Dyspnoea—Liotrix—hypothyroidism	0.00272	0.00421	CcSEcCtD
Aprepitant—CYP3A5—female gonad—hypothyroidism	0.0027	0.012	CbGeAlD
Aprepitant—Decreased appetite—Liotrix—hypothyroidism	0.00265	0.00411	CcSEcCtD
Aprepitant—Vomiting—Levothyroxine—hypothyroidism	0.00264	0.00409	CcSEcCtD
Aprepitant—Vomiting—Dextrothyroxine—hypothyroidism	0.00264	0.00409	CcSEcCtD
Aprepitant—TACR3—G alpha (q) signalling events—AVP—hypothyroidism	0.00263	0.0204	CbGpPWpGaD
Aprepitant—Fatigue—Liotrix—hypothyroidism	0.00263	0.00407	CcSEcCtD
Aprepitant—Rash—Levothyroxine—hypothyroidism	0.00262	0.00405	CcSEcCtD
Aprepitant—Rash—Dextrothyroxine—hypothyroidism	0.00262	0.00405	CcSEcCtD
Aprepitant—Dermatitis—Levothyroxine—hypothyroidism	0.00262	0.00405	CcSEcCtD
Aprepitant—Dermatitis—Dextrothyroxine—hypothyroidism	0.00262	0.00405	CcSEcCtD
Aprepitant—Constipation—Liotrix—hypothyroidism	0.00261	0.00404	CcSEcCtD
Aprepitant—TACR3—Peptide ligand-binding receptors—AVP—hypothyroidism	0.0026	0.0201	CbGpPWpGaD
Aprepitant—Headache—Levothyroxine—hypothyroidism	0.0026	0.00402	CcSEcCtD
Aprepitant—Headache—Dextrothyroxine—hypothyroidism	0.0026	0.00402	CcSEcCtD
Aprepitant—TACR3—GPCR ligand binding—TRH—hypothyroidism	0.00253	0.0196	CbGpPWpGaD
Aprepitant—Feeling abnormal—Liotrix—hypothyroidism	0.00252	0.00389	CcSEcCtD
Aprepitant—Gastrointestinal pain—Liotrix—hypothyroidism	0.0025	0.00386	CcSEcCtD
Aprepitant—Nausea—Levothyroxine—hypothyroidism	0.00247	0.00382	CcSEcCtD
Aprepitant—Nausea—Dextrothyroxine—hypothyroidism	0.00247	0.00382	CcSEcCtD
Aprepitant—TACR1—G alpha (q) signalling events—TRH—hypothyroidism	0.00245	0.0189	CbGpPWpGaD
Aprepitant—Urticaria—Liotrix—hypothyroidism	0.00243	0.00375	CcSEcCtD
Aprepitant—TACR1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00242	0.0187	CbGpPWpGaD
Aprepitant—Abdominal pain—Liotrix—hypothyroidism	0.00241	0.00374	CcSEcCtD
Aprepitant—Body temperature increased—Liotrix—hypothyroidism	0.00241	0.00374	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00236	0.0182	CbGpPWpGaD
Aprepitant—CYP1A2—liver—hypothyroidism	0.00235	0.0105	CbGeAlD
Aprepitant—CYP3A5—liver—hypothyroidism	0.00226	0.0101	CbGeAlD
Aprepitant—TACR3—GPCR ligand binding—TSHB—hypothyroidism	0.00225	0.0174	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—TSHR—hypothyroidism	0.00225	0.0174	CbGpPWpGaD
Aprepitant—Hypersensitivity—Liotrix—hypothyroidism	0.00225	0.00348	CcSEcCtD
Aprepitant—CYP2C9—liver—hypothyroidism	0.00223	0.00993	CbGeAlD
Aprepitant—Asthenia—Liotrix—hypothyroidism	0.00219	0.00339	CcSEcCtD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00219	0.0169	CbGpPWpGaD
Aprepitant—CYP3A4—blood—hypothyroidism	0.00217	0.00968	CbGeAlD
Aprepitant—Pruritus—Liotrix—hypothyroidism	0.00216	0.00334	CcSEcCtD
Aprepitant—Diarrhoea—Liotrix—hypothyroidism	0.00209	0.00323	CcSEcCtD
Aprepitant—Dizziness—Liotrix—hypothyroidism	0.00202	0.00313	CcSEcCtD
Aprepitant—Vomiting—Liotrix—hypothyroidism	0.00194	0.003	CcSEcCtD
Aprepitant—Rash—Liotrix—hypothyroidism	0.00193	0.00298	CcSEcCtD
Aprepitant—Dermatitis—Liotrix—hypothyroidism	0.00192	0.00298	CcSEcCtD
Aprepitant—Headache—Liotrix—hypothyroidism	0.00191	0.00296	CcSEcCtD
Aprepitant—Nausea—Liotrix—hypothyroidism	0.00181	0.00281	CcSEcCtD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00174	0.0135	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00173	0.0134	CbGpPWpGaD
Aprepitant—CYP3A4—liver—hypothyroidism	0.0017	0.00757	CbGeAlD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00162	0.0125	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00149	0.0115	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00145	0.0112	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00145	0.0112	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—TRH—hypothyroidism	0.00143	0.0111	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—AVP—hypothyroidism	0.00133	0.0103	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—TRH—hypothyroidism	0.0013	0.01	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—AVP—hypothyroidism	0.00129	0.00995	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—TSHB—hypothyroidism	0.00127	0.00986	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—TSHR—hypothyroidism	0.00127	0.00986	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00127	0.00983	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—TRH—hypothyroidism	0.00124	0.00956	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00116	0.00897	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—TSHB—hypothyroidism	0.00116	0.00895	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—TSHR—hypothyroidism	0.00116	0.00895	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00115	0.0089	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—TSHB—hypothyroidism	0.0011	0.00852	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—TSHR—hypothyroidism	0.0011	0.00852	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CLTC—hypothyroidism	0.000887	0.00686	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—POMC—hypothyroidism	0.000883	0.00683	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000852	0.00659	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000844	0.00653	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—VAV3—hypothyroidism	0.000779	0.00603	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TRH—hypothyroidism	0.000767	0.00593	CbGpPWpGaD
Aprepitant—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000762	0.0059	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—AVP—hypothyroidism	0.000751	0.00581	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—VAV3—hypothyroidism	0.000708	0.00547	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—TRH—hypothyroidism	0.000698	0.0054	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TSHB—hypothyroidism	0.000683	0.00529	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TSHR—hypothyroidism	0.000683	0.00529	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—AVP—hypothyroidism	0.000682	0.00527	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—AVP—hypothyroidism	0.000649	0.00502	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—TRH—hypothyroidism	0.000634	0.0049	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—TSHB—hypothyroidism	0.000622	0.00481	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—TSHR—hypothyroidism	0.000622	0.00481	CbGpPWpGaD
Aprepitant—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000618	0.00478	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SH2B3—hypothyroidism	0.000609	0.00471	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000566	0.00438	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—TSHB—hypothyroidism	0.000565	0.00437	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—TSHR—hypothyroidism	0.000565	0.00437	CbGpPWpGaD
Aprepitant—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000551	0.00426	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—POMC—hypothyroidism	0.000499	0.00386	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—POMC—hypothyroidism	0.000453	0.00351	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PRL—hypothyroidism	0.000452	0.0035	CbGpPWpGaD
Aprepitant—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000447	0.00345	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CLTC—hypothyroidism	0.000433	0.00335	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—POMC—hypothyroidism	0.000431	0.00334	CbGpPWpGaD
Aprepitant—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000426	0.00329	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VAV3—hypothyroidism	0.000418	0.00323	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—AVP—hypothyroidism	0.000403	0.00312	CbGpPWpGaD
Aprepitant—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000388	0.003	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—IYD—hypothyroidism	0.000387	0.003	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—VAV3—hypothyroidism	0.000381	0.00294	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TRH—hypothyroidism	0.000374	0.0029	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—AVP—hypothyroidism	0.000367	0.00284	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—VAV3—hypothyroidism	0.000346	0.00267	CbGpPWpGaD
Aprepitant—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000345	0.00267	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TSHB—hypothyroidism	0.000334	0.00258	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TSHR—hypothyroidism	0.000334	0.00258	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AVP—hypothyroidism	0.000333	0.00258	CbGpPWpGaD
Aprepitant—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000332	0.00257	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ATP5O—hypothyroidism	0.000329	0.00255	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—POMC—hypothyroidism	0.000328	0.00254	CbGpPWpGaD
Aprepitant—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000315	0.00244	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—TPO—hypothyroidism	0.00031	0.00239	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SH2B3—hypothyroidism	0.000297	0.0023	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—IYD—hypothyroidism	0.00028	0.00217	CbGpPWpGaD
Aprepitant—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000269	0.00208	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—POMC—hypothyroidism	0.000268	0.00207	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IGF1—hypothyroidism	0.000257	0.00199	CbGpPWpGaD
Aprepitant—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000256	0.00198	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—POMC—hypothyroidism	0.000244	0.00189	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ATP5O—hypothyroidism	0.000238	0.00184	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—POMC—hypothyroidism	0.000237	0.00184	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TPO—hypothyroidism	0.000224	0.00173	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—POMC—hypothyroidism	0.000221	0.00171	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PRL—hypothyroidism	0.000221	0.00171	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—IYD—hypothyroidism	0.000216	0.00167	CbGpPWpGaD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000208	0.00161	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VAV3—hypothyroidism	0.000204	0.00158	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—IYD—hypothyroidism	0.000197	0.00153	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AVP—hypothyroidism	0.000197	0.00152	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ATP5O—hypothyroidism	0.000184	0.00142	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—POMC—hypothyroidism	0.000183	0.00142	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TPO—hypothyroidism	0.000173	0.00134	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—IYD—hypothyroidism	0.000169	0.0013	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ATP5O—hypothyroidism	0.000168	0.0013	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—POMC—hypothyroidism	0.000167	0.00129	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00016	0.00124	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TPO—hypothyroidism	0.000158	0.00122	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000146	0.00113	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ATP5O—hypothyroidism	0.000143	0.00111	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—TSHB—hypothyroidism	0.000143	0.00111	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—POMC—hypothyroidism	0.000143	0.00111	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TPO—hypothyroidism	0.000135	0.00104	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—POMC—hypothyroidism	0.000131	0.00101	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—IYD—hypothyroidism	0.00013	0.00101	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	0.000128	0.000988	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IGF1—hypothyroidism	0.000126	0.000973	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000125	0.000966	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ATP5O—hypothyroidism	0.000111	0.000856	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—POMC—hypothyroidism	0.00011	0.000853	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SLC5A5—hypothyroidism	0.000107	0.00083	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TPO—hypothyroidism	0.000104	0.000805	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TSHB—hypothyroidism	0.000104	0.000801	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	9.23e-05	0.000714	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TSHB—hypothyroidism	8.01e-05	0.00062	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SLC5A5—hypothyroidism	7.75e-05	0.0006	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TSHB—hypothyroidism	7.3e-05	0.000565	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	7.14e-05	0.000552	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.04e-05	0.000545	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	6.51e-05	0.000503	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.42e-05	0.000497	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TSHB—hypothyroidism	6.24e-05	0.000483	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC5A5—hypothyroidism	5.99e-05	0.000464	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—POMC—hypothyroidism	5.61e-05	0.000434	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	5.56e-05	0.00043	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.49e-05	0.000425	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC5A5—hypothyroidism	5.47e-05	0.000423	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TSHB—hypothyroidism	4.82e-05	0.000373	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC5A5—hypothyroidism	4.67e-05	0.000361	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	4.29e-05	0.000332	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—POMC—hypothyroidism	4.06e-05	0.000314	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC5A5—hypothyroidism	3.61e-05	0.000279	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—POMC—hypothyroidism	3.14e-05	0.000243	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—POMC—hypothyroidism	2.86e-05	0.000221	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—POMC—hypothyroidism	2.44e-05	0.000189	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—POMC—hypothyroidism	1.89e-05	0.000146	CbGpPWpGaD
